Clinical Trial Update: Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating adaptive therapy with capecitabine for metastatic estrogen receptor-positive, HER2-negative breast cancer; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Mayo Clinic | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen-receptor-positive Breast Cancer | Phase 2 | Status: RECRUITING